Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NeuroVive Pharmaceutical AB | -2,594,793 | net | 07 Mar 2025 | tx 8+1,960,438−4,555,231 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Mar 2025 | SALE | NeuroVive Pharmaceutical AB | 574,978 | 0.45 SEK | |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 1,750,000 | 0.05 SEK | deriv |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 277,850 | 0.03 SEK | deriv |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 891,498 | 0.45 SEK | |
| 30 May 2024 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 1,750,000 | 0.03 SEK | deriv |
| 17 Apr 2024 | PURCHASE | NeuroVive Pharmaceutical AB | 191,031 | 0.16 SEK | first after silence |
| 24 Apr 2018 | PURCHASE | NeuroVive Pharmaceutical AB | 19,407 | 8.00 SEK | |
| 20 Apr 2018 | SALE | NeuroVive Pharmaceutical AB | 1,060,905 | 0.01 SEK |
1 purchase reported after at least 12 months of silence — most recent on 17 Apr 2024.